Weight-loss drugs tied to lower fracture risk in diabetes patients, study finds

Weight-loss medicines linked to 21% lower fracture risk in type 2 diabetes patients, a new study found, challenging assumptions that rapid weight loss inevitably raises fracture risk.

Those receiving the drug were found to be 33 per cent less likely to suffer a heart attack when compared to patients on another type 2 diabetes medication

WEIGHT loss jab Mounjaro could slash the risk of life-threatening heart attacks, a study suggests. Tirzepatide, the powerful ingredient behind Mounjaro, has long been been hailed a monumental breakthrough in the war on obesity and type 2 diabetes. Now, US researchers have found that those taking the jab were 33 per cen

Two people in Australia are diagnosed with ALS each day. Researchers say working with pesticides could bring a 70 per cent greater risk of developing the fatal disease.

The study didn’t include uninsured families or those on Medicaid, which means the data may be skewed.

Pancreatitis — how great is the risk of weight-loss medication?  The Times

CEO Brian Moynihan says GLP-1 medications now account for roughly 13% of the bank's total annual healthcare spending

The Danish company developed the most lucrative new drug the world had ever seen. Then America’s Eli Lilly outmaneuvered it and took control of the diet-drug market.

Retatrutide — also known as "reta" — has been shown to produce dramatically greater weight loss than Ozempic and Mounjaro.

Writing in the prestigious medical journal The Lancet, the researchers - from Canada and the UK - say the findings suggest medics may fail to recognise eating disorders other than anorexia.

Air Force, Coast Guard and Navy veterans had the highest rates of ALS diagnosis in an analysis of more than 14,400 cases.

International research suggests losing weight may help people get a job - and their New Zealand counterparts say it can't be ruled out here, either.

The trial, which will take place at 18 VA hospitals, will involve 600 veterans.

A corresponding author told Newsweek that delaying social media use until around ages 13 to 14 may help protect learning outcomes.

Drugmaker Eli Lilly says it is expanding access to its experimental weight loss drug, retatrutide, which has not been approved yet by the FDA. The company says obese patients taking the drug in clinical trials lost between 73 and 85 pounds over two years. Dr. Rachel Pessah Pollack discusses what we know about its safet

A breast cancer surgeon explains how GLP-1 drugs like Ozempic and Wegovy may lower cancer recurrence risk by reducing BMI, estrogen and inflammation.

Jaime says TikTok taught her how to buy and inject black market peptides. Months later, she had lost 17kg.